Prothena Plc

(NASDAQ) PRTA

Current Price$9.78

Market Cap$510.97M

Since IPO (2012)+36%

5 Year-58%

1 Year+45%

1 Month-10%

Prothena Plc Financials at a Glance

Market Cap

$510.97M

Revenue (TTM)

$57.94M

Net Income (TTM)

$151.18M

EPS (TTM)

$-2.81

P/E Ratio

-3.47

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$9.78

Volume

44,229

Open

$9.80

Price

$9.78

Volume

44,229

Open

$9.80

Previous Close

$9.78

Daily Range

$9.46 - $9.86

52-Week Range

$4.32 - $11.80

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$9.78

Volume

44,229

Open

$9.80

Previous Close

$9.78

Daily Range

$9.46 - $9.86

52-Week Range

$4.32 - $11.80

PRTA News

Page 1

PRTA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prothena Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Gene G. Kinney, PhD

Website

www.prothena.com

Headquarters

Dublin, 2, IE

PRTA Financials

Key Financial Metrics (TTM)

Gross Margin

47%

Operating Margin

-2%

Net Income Margin

-3%

Return on Equity

-40%

Return on Capital

-40%

Return on Assets

-43%

Earnings Yield

-28.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$510.97M

Shares Outstanding

52.35M

Volume

44.23K

Avg. Volume

510.21K

Financials (TTM)

Gross Profit

$5.98M

Operating Income

$184.56M

EBITDA

$197.13M

Operating Cash Flow

$163.58M

Capital Expenditure

$138.00K

Free Cash Flow

$163.72M

Cash & ST Invst.

$307.53M

Total Debt

$13.86M

Prothena Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$51.08M

+1706.4%

Gross Profit

$50.17M

+1673.9%

Gross Margin

98.20%

N/A

Market Cap

$510.97M

N/A

Market Cap/Employee

$3.13M

N/A

Employees

163

N/A

Net Income

$32.72M

+154.4%

EBITDA

$26.71M

+140.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$321.81M

-21.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.76M

-37.1%

Short Term Debt

$2.89M

+10.1%

Return on Assets

-43.21%

N/A

Return on Invested Capital

-39.79%

N/A

Free Cash Flow

$28.88M

+154.1%

Operating Cash Flow

$28.88M

+154.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RIGLRigel Pharmaceuticals, Inc.

RIGLRigel Pharmaceuticals, Inc.$29.01-9.12%

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$9.15-6.73%

NMRANeumora Therapeutics, Inc. Common Stock

NMRANeumora Therapeutics, Inc. Common Stock$1.84-6.60%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$4.45-4.71%

VSTMVerastem, Inc.

VSTMVerastem, Inc.$4.32-8.28%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.34+3.03%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

NOKNokia

NOKNokia$13.95-0.04%

ONDSOndas

ONDSOndas$10.62-0.05%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$19.87-0.10%

Questions About PRTA

What is the current price of Prothena Plc?

Prothena Plc is trading at $9.78 per share.

What is the 52-week range for Prothena Plc?

Over the past 52 weeks, Prothena Plc has traded between $4.32 and $11.80.

How much debt does Prothena Plc have?

As of the most recent reporting period, Prothena Plc reported total debt of $7.65M.

How much cash does Prothena Plc have on hand?

Prothena Plc reported $329.46M in cash and cash equivalents in its most recent financial results.

What is Prothena Plc’s dividend yield?

Prothena Plc does not currently have a dividend yield.

Prothena Plc

Prothena Plc Financials at a Glance

PRTA News

Prothena Q2 Revenue Drops 97%

With Prothena Up Over 500% This Year, Is It Too Late to Get in?

Lessons to Learn From April's Biotech Blowups

Why Prothena Corporation plc Is Imploding Today

Why Prothena Corp plc Shot 14.4% Higher Today

The Reason Behind Prothena Corporation PLC's Plunge of as Much as 25%

Why Prothena Corp plc Skyrocketed 43% in July

3 Best Stocks for Risk-Tolerant Investors

PRTA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Prothena Plc

PRTA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Prothena Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRTA

What is the current price of Prothena Plc?

What is the 52-week range for Prothena Plc?

How much debt does Prothena Plc have?

How much cash does Prothena Plc have on hand?

What is Prothena Plc’s dividend yield?

Premium Investing Services